AASLD: American Association for the Study of Liver Diseases
Your network for the investigation and treatment of liver diseases Home | About Us | Log In/Out | Member Center | Site Map
Register for The Liver Meeting 
Program
AASLD’s Annual Meeting defines the cutting edge in the study and treatment of liver and biliary diseases and offers the best possible atmosphere to discuss groundbreaking research and progressive clinical treatments.

Program 
|

 

Friday, October 30  
6:30 am – 8:00 pm Registration 
Noon – 4:00 pm Career Development Workshop
4:00 – 8:00 pm Postgraduate Course: Keeping the Patient with End-stage Cirrhosis Alive
   
Saturday, October 31  
6:30 am – 8:00 pm Registration
8:00 am – 5:15 pm Postgraduate Course: Keeping the Patient with End-stage Cirrhosis Alive
Sunday, November 1    
6:30 am – 6:00 pm Registration
9:30 – 10:00 am  Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture: What is Critical for Liver Surgery and Partial Liver Transplantation - Size or Quality?
Noon – 12:30 pm Hans Popper State-of-the-Art Lecture: The Biology and Therapeutic Potential of Small RNAs
2:00 – 2:30 pm President’s Choice: Advocacy in Washington – A New Horizon for the Liver Disease Community
1:00 – 4:00 pm General Hepatology Update I: Ascites Management in Older Patients; Update in the Treatment of Non-alcoholic Fatty Liver Disease; Liver Cancer Screening: Modalities and Benefits
3:00 - 4:30 pm Integrity Research Workshop: Ethical Challenges in Data Management and Publication of Hepatology Research
Monday, November 2
6:30 am – 6:00 pm Registration
6:45 – 7:45 am Early Morning Workshops
8:00 – 9:30 am Presidential Plenary I
8:00 am – 5:30 pm Poster Session III (presentation time 1:00 – 2:30pm)
9:30 – 10:00 am Award Presentations (DAA and DSA)
9:30 am – 3:00 pm Exhibits Open
10:00 – 10:30 am Hyman J Zimmerman Hepatoxicity State-of-the-Art Lecture: Bioartificial Livers and Their Potential Use in Drug Toxicity Screening
11:00 am – 12:30 pm Presidential Plenary II
11:00 am – 12:30 pm Advances for Practitioners
3:00 – 4:30 pm Parallel Sessions
3:00 – 4:30 pm  General Hepatology Update II: Management of Hepatic Encephalopathy; Alcoholic Liver Disease; Acute Liver Failure
3:00 – 4:30 pm Global HCC Update (AASLD/EASL/APASL): International Management Strategies for HCC in Patients with Advanced Liver Disease
4:45 – 6:15 pm  Late-breaking Abstracts
4:45 – 6:15 pm Parallel Sessions
5:00 – 6:30 pm  Practice Management Workshop
6:30 pm Industry-supported Satellite Symposia
7:00 – 10:00 pm Focused Study Groups
1. Primary Prophylaxis of Variceal Hemorrhage in Children: Can We Really do a Randomized Trial?
2. Cellular Targets of Lipotoxicity in NAFLD
7:00 – 10:00 pm Mini-symposia
1. Diagnosis and Treatment of Very Early Stage HCC
2. Antifibrotic Therapy – Translation into the Clinic
3. Recent Advances in the Management of Minimal and Overt Hepatic Encephalopathy – Are We There Yet?
Tuesday, November 3
6:30 am – 12:30 pm Registration
6:45 – 7:45 am Early Morning Workshops
8:00 – 9:30 am Presidential Plenary III 
9:30 – 9:45 am Award Presentation (Distinguished Clinician Educator/Mentor)
8:00 am – 1:00 pm Poster Session IV
9:45 – 10:15 am Leon Schiff State-of-the-Art Lecture: Hemochromatosis - a New Disease Paradigm
10:15 am - Noon HCC Global Update
11:30 am– 1:00 pm Parallel Sessions
Note: Program Subject to Change